Criteria for the Diagnosis of Lupus Anticoagulants: An Update: On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH

Brandt, John T, Triplett, Douglas A, Alving, Barbara, Scharrer, Inge·1995·Thrombosis and Haemostasis
DOI 10.1055/s-0038-1649901

Cited by (993)

Items 501–600 of 993

  1. The investigation of the significance of a positive direct antiglobulin test in blood donors
    Marianna Bellia, J. Georgopoulos, V. Tsevrenis · 2002 · Immunohematology
  2. Purpura and leg ulcers in a patient with cryoglobulinaemia, non-Hodgkin's lymphoma, and antiphospholipid syndrome
    Sladjana Andrejević, Branka Bonaci Nikolic, Mirjana Bukilica · 2003 · Clinical and Experimental Dermatology
  3. Antiphospholipid scoring: significance in diagnosis and prognosis
    Kenji Oku, Olga Amengual, Tatsuya Atsumi · 2014 · Lupus
  4. Characterization of chronic arthritis in a multicenter study of 852 childhood-onset systemic lupus erythematosus patients
    Ana Paula Sakamoto, Clóvis A. Silva, Mariana Paes Leme Ferriani et al. · 2016 · Rheumatology International
  5. Catastrophic Antiphospholipid Syndrome: A Review
    Carmine Siniscalchi, Manuela Basaglia, Michele Augusto Riva, Michele Meschi, Tiziana Meschi, Giampiero Castaldo, Pierpaolo Di Micco · 2023 · Immuno
  6. Treatment of the antiphospholipid syndrome
    Monica Galli · 2013 · Autoimmunity Highlights
  7. Antiphosphatidylserine antibodies as diagnostic indicators of antiphospholipid syndrome
    Haitham A. Khogeer, Areej A. G. AlFattani, M Al Kaff · 2014 · Lupus
  8. Clinical significance of anti-protein Z antibodies in patients with lupus anticoagulant
    Thomas Sailer, Rainer Vormittag, Silvia Koder · 2007 · Thrombosis Research
  9. Two antiprothrombin antibodies against prothrombin and prothrombin–phosphatidyl serine show partial but not total identity
    J Matsuda, T Sanaka, A Nishizawa · 2002 · Blood Coagulation & Fibrinolysis
  10. Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score
    Massimo Radin, Irene Cecchi, Karen Ingrid Schreiber, Elena Rubini, Dario Roccatello, María José Cuadrado, Savino Sciascia · 2020 · Seminars in Arthritis and Rheumatism
  11. Does Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) Predict the Obstetric Outcome in Antiphospholipid Antibody Carriers? A Single-Center Study
    Sara Del Barrio-Longarela, Víctor Manuel Martínez-Taboada, Pedro Blanco-Olavarri, Ana Merino, Leyre Riancho‐Zarrabeitia, Alejandra Comins‐Boo, Marcos López‐Hoyos, José L. Hernández · 2021 · Clinical Reviews in Allergy & Immunology
  12. Longitudinal evaluation of markers of endothelial cell dysfunction and hemostasis in treated antiphospholipid syndrome and in healthy pregnancy
    Sophia Stone, Beverley Jane Hunt, Paul Townsend Seed · 2003 · American Journal of Obstetrics and Gynecology
  13. Renal manifestations of the antiphospholipid syndrome
    David P. D’Cruz · 2009 · Current Rheumatology Reports
  14. Acquired Activated Protein C Resistance Caused by Lupus Anticoagulants
    Adam J. Saenz, Nicholas V. Johnson, Elizabeth M. Van Cott · 2011 · American Journal of Clinical Pathology
  15. S100β is associated with cognitive impairment in childhood-onset systemic lupus erythematosus patients
    A.T. Lapa, Mariana Postal, N.A. Sinicato · 2017 · Lupus
  16. Impaired factor XIIa–dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications
    Francisco Carmona, Isabel Lázaro, Joan Carles Reverter, Dolors Tàssies, Josep Font, Ricard Cervera, Juan Balasch · 2006 · American Journal of Obstetrics and Gynecology
  17. Idiopathic Intracranial Hypertension: Associations with Thrombophilia and Hypofibrinolysis in Men
    Charles J. Glueck, Naila Goldenberg, Karl C. Golnik · 2005 · Clinical and Applied Thrombosis/Hemostasis
  18. Laboratory thrombophilias and venous thromboembolism
    Hylton V. Joffe, Samuel Zachary Goldhaber · 2002 · Vascular Medicine
  19. Improved detection of lupus anticoagulants by the dilute Russell's Viper venom time
    Gary W. Moore, G.F. Savidge, M. Smith · 2000 · Blood Coagulation & Fibrinolysis
  20. Mechanism of action of β2-glycoprotein I-dependent lupus anticoagulants
    Jef Amout, J. Vermylen · 1998 · Lupus
  21. Thrombophilia screening – at the right time, for the right patient, with a good reason
    Mojca Stegnar · 2010 · Clinical Chemistry and Laboratory Medicine (CCLM)
  22. Cutaneous vasculitis in SLE
    Romy Kallas, DANIEL W. GOLDMAN, Michelle Petri · 2020 · Lupus Science & Medicine
  23. 16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome
    Savino Sciascia, Massimo Radin, Irene Cecchi, Roger A. Levy, Doruk Erkan · 2021 · Lupus
  24. Heterogeneity of Russell's viper venom affects the sensitivity of the dilute Russell's viper venom time to lupus anticoagulants
    Gary W. Moore, Geoffrey F. Savidge · 2004 · Blood Coagulation & Fibrinolysis
  25. Decreased incidence of lupus nephritis in northern Norway is linked to increased use of antihypertensive and anticoagulant therapy
    Gro Østli Eilertsen, Silje Fismen, Tove Aminda Hanssen · 2010 · Nephrology Dialysis Transplantation
  26. Expansion of myelin autoreactive CD8+ T lymphocytes in patients with neuropsychiatric systemic lupus erythematosus
    Cécile Contin‐Bordes, Estibaliz Lazaro, Christophe Richez · 2010 · Annals of the Rheumatic Diseases
  27. Abnormal optical waveform profiles in coagulation assays from patients with antiphospholipid antibodies
    Z. Su, Paul J. Braun, K F Klemp, K. R. Baker, Elizabeth H. Thames, Thomas L. Ortel · 2002 · Blood Coagulation & Fibrinolysis
  28. Prevalence of antiphospholipid antibodies in psychiatric patients users and non‐users of antipsychotics
    Aurélien Delluc, Aurélie Rousseau, Mickaël Le Galudec · 2013 · British Journal of Haematology
  29. Association of autoantibodies to heat‐shock protein 60 with arterial vascular events in patients with antiphospholipid antibodies
    Dieudé, Mélanie, Correa, José A., Neville, Carolyn, Pineau, Christian, Levine, Jerrold S., Subang, Rebecca, Landolt‐Marticorena, Carolina, Su, Jiandong, Kassis, Jeannine, Solymoss, Susan et al. · 2011 · Arthritis & Rheumatism
  30. The clinical value of testing for antibodies to phosphatidylethanolamine (aPE) in patients with systemic lupus erythematosus (SLE)
    María Laura Bertolaccini, Veronica Murru, Savino Sciascia, Giovanni Sanna, Munther A. Khamashta · 2012 · Thrombosis Research
  31. Diagnostic algorithm for thrombophilia screening
    Sandra Margetić · 2010 · Clinical Chemistry and Laboratory Medicine (CCLM)
  32. Antithyroid antibodies in antiphospholipid syndrome: prevalence and clinical associations
    C. Mavragani, Stamatina Danielides, Elias Zintzaras · 2009 · Lupus
  33. Myeloablative immunosuppressive treatment with autologous haematopoietic stem cell transplantation in a patient with psoriatic arthropathy and monoclonal gammopathy of undetermined significance
    Martin Mohren, T Daikeler, D Benz · 2004 · Annals of the Rheumatic Diseases
  34. Controversies and Unresolved Issues in Antiphospholipid Syndrome Pathogenesis and Management
    William Baker, Rodger L. Bick, Jawed Fareed · 2008 · Hematology/Oncology Clinics of North America
  35. The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant
    Chris Gardiner, Ian J. Mackie, R G Malía · 2000 · British Journal of Haematology
  36. Intracardiac thrombosis and fever possibly triggered by ovulation induction in a patient with antiphospholipid antibodies
    Sladjana Andrejević, Branka Bonaci Nikolic, Mirjana Bukilica · 2002 · Scandinavian Journal of Rheumatology
  37. Anticardiolipin Antibodies and Ocular Disease
    Filipe Cabrita, Charles Stephen Foster · 2005 · Ocular Immunology and Inflammation
  38. Antiphospholipid-Mediated Thrombosis: Interplay Between Anticardiolipin Antibodies and Vascular Cells
    Chary López-Pedrera, Paula Buendía, Nuria Barbarroja · 2006 · Clinical and Applied Thrombosis/Hemostasis
  39. Differences in anti-phosphatidylserine-prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa
    T. Kawakami, M. Yamazaki, M. Mizoguchi, Y. Soma · 2008 · Rheumatology
  40. Immunotherapy for recurrent pregnancy loss: ?Standard of care or buyer beware?
    Joshua Aiden Hill · 1997 · Journal of the Society for Gynecologic Investigation
  41. Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis
    Johannes Jakobsen Sidelmann, Jonas Angel Sjøland, Jørgen Gram, Vivian Bertelsen, Torben Mourits‐Andersen, Henrik Münster, Anna‐Marie Bloch Münster, Jørgen Jespersen · 2007 · Scandinavian Journal of Clinical and Laboratory Investigation
  42. Deciphered coagulation profile to diagnose the antiphospholipid syndrome using artificial intelligence
    Romy Kremers, Denis G. Wahl, Stéphane Zuily, Marisa Ninivaggi, Walid Chayouâ, Véronique Regnault, Jacek Musiał, Philip G. de Groot, Katrien M.J. Devreese, Bas de Laat · 2021 · Thrombosis Research
  43. Specificity and sensitivity of anti-β2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome
    Virunya Parkpian, Oravan Verasertniyom, Monchand Vanichapuntu et al. · 2007 · Clinical Rheumatology
  44. Subclinical Pulmonary Hypertension in Childhood Systemic Lupus Erythematosus Associated with Minor Disease Manifestations
    Pedro Anuardo, M Verdier, Natali W.S. Gormezano et al. · 2016 · Pediatric Cardiology
  45. Evaluation of a new silica clotting time in the diagnosis of lupus anticoagulants
    Katrien M.J. Devreese · 2006 · Thrombosis Research
  46. Laboratory identification of lupus anticoagulants
    Kristi Johnson Smock, George M. Rodgers · 2009 · American Journal of Hematology
  47. Laboratory Evaluation of Antiphospholipid Antibodies in Patients With Venous Thromboembolism
    Jana Hirmerová, Zdenka Ulcova-Gallova, Jitka Seidlerová, Jan Filipovský, K Bibková, Zdenka Mičanová, Otto Mayer · 2009 · Clinical and Applied Thrombosis/Hemostasis
  48. Anti-Ro/SSA antibodies are associated with severe mitral valve regurgitation in patients with systemic lupus erythematosus
    Violeta Higuera‐Ortiz, Tania Mora-Arias, Diana Castillo‐Martínez · 2016 · Modern Rheumatology
  49. Symmetrical peripheral gangrene complicating Klebsiella pneumoniae sepsis associated with antiphospholipid antibodies
    Yoo Jh, J-K Min, S-S Kwon · 2004 · Annals of the Rheumatic Diseases
  50. Management of Thrombosis in Women With Antiphospholipid Syndrome
    Nitin B. Chandramouli, George M. Rodgers · 2001 · Clinical Obstetrics & Gynecology
  51. Antiphospholipid syndrome in patients with retinal venous occlusion
    Marc Paccalin, H. Manic, Gauthier Bouche, C. Landron, Martial Mercié, Catherine Boinot, Jean‐Marc Gombert, P. Roblot, P. Dighiero · 2005 · Thrombosis Research
  52. Double valve replacement in a patient with anticardiolipin antibody syndrome
    Gerard J. Myers, Gregory Marshal Hirsch · 1999 · Perfusion
  53. Efficacy and safety of nadroparin in the treatment of pregnant women with antiphospholipid syndrome: a prospective cohort study
    Amelia Ruffatti, Maria Favarò, Marta Tonello · 2005 · Lupus
  54. Biometria do fígado e do baço em pacientes com lúpus eritematoso sistêmico de início pediátrico
    Andressa Guariento, Marco Felipe C. Silva, Priscilla S.F. Tassetano · 2015 · Revista Brasileira de Reumatologia
  55. New guidelines for lupus anticoagulant: sensitivity and specificity of cut-off values calculated with plasmas from healthy controls in mixing and confirmatory tests
    MARTINUZZO, M. E., CERRATO, G. S., VARELA, M. L. I., ADAMCZUK, Y. P., FORASTIERO, R. R. · 2012 · International Journal of Laboratory Hematology
  56. Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers
    Shruti Chaturvedi, Keith R. McCrae · 2017 · Current Rheumatology Reports
  57. Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study
    Iana Sousa Nascimento, Massimo Radin, Ana Paula Rossi Gândara, Savino Sciascia, DANIELI CASTRO OLIVEIRA DE ANDRADE · 2020 · Lupus
  58. Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus
    Ana Paula Sakamoto, Clóvis A. Silva, Aline Garcia Islabão, Glaucia Vanessa Novak, Beatriz C. Molinari, Paulo César Koch Nogueira, Rosa Maria Rodrigues Pereira, Claudia Saad‐Magalhães, Gleice Clemente, Daniela Gerent Petry Piotto et al. · 2022 · Pediatric Nephrology
  59. Laboratory Diagnosis of the Lupus Anticoagulant
    Thomas L. Ortel · 2011 · Current Rheumatology Reports
  60. Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies
    Maria Ángeles Martínez‐Zamora, Dolors Tàssies, Francisco Carmona · 2010 · Journal of Reproductive Immunology
  61. APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus
    Gro Østli Eilertsen, Johannes Cornelis Nossent · 2014 · Lupus
  62. Cutaneous vasculitis in systemic lupus erythematosus: association with anti-ribosomal P protein antibody and Raynaud phenomenon
    Samuel Katsuyuki Shinjo, Eloísa Bonfá · 2010 · Clinical Rheumatology
  63. Multiple rib infarcts: a rare form of osteonecrosis in antiphospholipid syndrome
    W-H Yoo · 2004 · Annals of the Rheumatic Diseases
  64. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities
    I. Martinelli, Tullia Battaglioli, Paolo Bucciarelli · 2004 · ACC Current Journal Review
  65. Monitoring Therapy with Vitamin K Antagonists in Patients with Lupus Anticoagulant: Effect on Different Tests for INR Determination
    Nick R. Bijsterveld, Saskia Middeldorp, Fenny Berends, Harry Roger Buller · 2000 · Journal of Thrombosis and Thrombolysis
  66. Evaluation of three commercial ELISA kits for anticardiolipin and anti‐beta2‐glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome
    An-Sofie C. Decavele, Sofie Schouwers, Katrien M.J. Devreese · 2010 · International Journal of Laboratory Hematology
  67. Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss
    C Bu, C Zhang, Zheng Li · 2007 · Clinical & Experimental Immunology
  68. Lupus anticoagulant in immune thrombocytopenic purpura
    Sumitra Dash, Ram Kumar Marwaha, Sambit Kumar Mohanty · 2004 · The Indian Journal of Pediatrics
  69. Acquired thrombophilic syndromes
    Daniela Elena Matei, Benjamin Brenner, Victor J. Marder · 2001 · Blood Reviews
  70. Are anticardiolipin antibodies really important in thromboangiitis obliterans (Buerger’s disease)?
    Jeffrey W. Olin · 2002 · Vascular Medicine
  71. Antiphospholipid syndrome, cardiac surgery and cardiopulmonary bypass
    VipulKrishen Sharma, Ravindra Chaturvedi, VSM Manoj Luthra · 2011 · Annals of Cardiac Anaesthesia
  72. Skin damage occurs early in systemic lupus erythematosus and independently of disease duration in Brazilian patients
    Juliana Guarize, Simone Appenzeller, Lílian Tereza Lavras Costallat · 2006 · Rheumatology International
  73. Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome
    Reyhan Diz Küçükkaya, Veysel Sabri Hançer, Murat İnanç, Meliha Nalçacı, Yüksel Pekçelen · 2004 · Lupus
  74. Sensitivity of the ProC® Global Assay for Protein C Pathway Abnormalities
    Pierre A. Toulon, Raphaël Adda, Patricia Perez · 2001 · Thrombosis Research
  75. The 20210A Allele of the Prothrombin Gene Is Frequent in Young Women With Unexplained Spinal Cord Infarction
    Éric Mercier, Isabelle Quéré, Chantal Campello · 1998 · Blood
  76. Does the presence of secondary antiphospholipid syndrome in patients with systemic lupus erythematodes accelerate carotid arteries intima-media thickness changes?
    Aleksandra Djoković, Lj. Stojanovich, Nataša Stanisavljević · 2013 · Rheumatology International
  77. Diagnostic biologique du syndrome des antiphospholipides : des critères à la pratique
    Valentin Joste, Marie‐Agnès Dragon‐Durey, Luc Darnige · 2017 · La Revue de Médecine Interne
  78. Antithrombin plasma levels decrease is associated with preeclampsia worsening
    Marco Marietta, L. SIMONI, Paola Pedrazzi · 2008 · International Journal of Laboratory Hematology
  79. Low extracellular vesicle–associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis
    Lena Hell, Cihan Ay, Florian Posch, Johanna Gebhart, Silvia Koder, Nigel Mackman, Ingrid Pabinger, J. Thaler · 2018 · Annals of Hematology
  80. Sclerosing panniculitis is associated with pulmonary hypertension in systemic sclerosis
    Masatoshi Jinnin, Hironobu Ihn, Yoshihide Asano · 2005 · British Journal of Dermatology
  81. Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene
    Eva Marie Jacobsen, Elin J Trettenes, Finn Wislöff, Ulrich Abildgaard · 2006 · Thrombosis Journal
  82. A prospective study of the prevalence of heparin‐induced antibodies and other associated thromboembolic risk factors in pediatric patients undergoing hemodialysis
    Hadef Skouri, R. Gandouz, Saoussen Abroug · 2006 · American Journal of Hematology
  83. Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients
    S Kashef, Mehran Karimi, Zahra Amirghofran · 2007 · International Journal of Laboratory Hematology
  84. Hypercoagulable state testing and malignancy screening following venous thromboembolic events
    Steven R. Deitcher, Marcelo P. Villa-Forte Gomes · 2003 · Vascular Medicine
  85. The Activated Seven Lupus Anticoagulant (ASLA) assay: a new test for lupus anticoagulants (LAs). Evidence that some LAs are detectable only in extrinsic pathway-based assays
    Gary W. Moore, Mark P. Smith, Y Patel, G.F. Savidge · 2002 · Blood Coagulation & Fibrinolysis
  86. Immunological and Molecular Analysis of Three Monoclonal Lupus Anticoagulant Antibodies from a Patient with Systemic Lupus Erythematosus
    Chung-Jeng Lai, Joyce Rauch, Chul Soo Cho · 1998 · Journal of Autoimmunity
  87. Binding properties of antibodies to prothrombin and β2-glycoprotein I (β2-GPI) assayed by ELISA and dot blot
    P R Forastiero, Marta Elba Martinuzzo, Luis O. Carreras · 1999 · Clinical & Experimental Immunology
  88. Combined plasmapheresis and immunosuppression as rescue treatment of a patient with catastrophic antiphospholipid syndrome occurring despite anticoagulation
    Steffen Koschmieder, Wolfgang Miesbach, Florian W.B. Fauth · 2003 · Blood Coagulation & Fibrinolysis
  89. Impact of the 2023 ACR/EULAR Classification Criteria in Women with Primary Antiphospholipid Syndrome during Pregnancy
    Víctor Manuel Martínez-Taboada, Ana Micieces Gómez, Sara Del Barrio-Longarela, Ana Merino, Alejandra Comins‐Boo, Marcos López‐Hoyos, Leyre Riancho‐Zarrabeitia, Rafael Gálvez, José L. Hernández · 2024 · Diagnostics
  90. European registry of babies born to mothers with antiphospholipid syndrome: a result update
    MC Boffa, Eric Lachassinne, Catherine Boinot, Sara De Carolis, Patrizia Querini Rovere, Tadej Avčin, Chiara Biasini Rebaioli, Philippe Le Toumelin, M.H. Aurousseau, Anǵela Tincani · 2009 · Lupus
  91. Long-term safety and effectiveness of mycophenolate mofetil in adults with lupus nephritis: a real-world study in Japan
    Tsutomu Takeuchi, Hideyuki Hashimoto, Mika Matsumoto · 2021 · Modern Rheumatology
  92. False‐positive results in ELISA‐based anti FVIII antibody assay may occur with lupus anticoagulant and phospholipid antibodies
    Mervyn A. Sahud, Olga S. Zhukov, K. MO, Joanna M. Popov, Jeffrey S. Dlott · 2012 · Haemophilia
  93. Valine/Leucine247 polymorphism of β2-glycoprotein I in patients with antiphospholipid syndrome: lack of association with anti-β2-glycoprotein I antibodies
    Jakub Swadźba, Marek Sanak, Teresa Iwaniec · 2006 · Lupus
  94. Reference Intervals of the Dilute Tissue Thromboplastin Inhibition and Dilute Russell's Viper Venom Tests Revisited
    Rolandas Gerbutavičius, Jawed Fareed, Harry L. Messmore, Omer Iqbal, Debra A. Hoppensteadt, William H. Wehrmacher, Muzaffer Demir, Peter Piccolo, Sarfraz Ahmad, Qing Ma et al. · 2002 · Clinical and Applied Thrombosis/Hemostasis
  95. Platelet and endothelial activation are requisites for the development of antiphospholipid syndrome
    E del Rio Garcia, Carmen S Rodriguez, J Rodríguez-Martorell, A Serrano, J.A. Girón González · 2004 · Annals of the Rheumatic Diseases
  96. Antiphospholipid antibodies as biomarkers in psychiatry: review of psychiatric manifestations in antiphospholipid syndrome
    Sanil Rege, Charles G. Mackworth-Young · 2015 · Translational Developmental Psychiatry
  97. Antiphospholipid Syndrome Associated with Malignant Mesothelioma Presenting with Superior Vena Cava Thrombosis: A Case Report
    Metin Özkan, Bülent Eser, Ozlem Soyer Er · 2004 · Clinical and Applied Thrombosis/Hemostasis
  98. Short-form arthritis impact measurement scales 2: Tests of reliability and validity among patients with osteoarthritis
    Ren, Xinhua S., Kazis, Lewis, Meenan, Robert F. · 1999 · Arthritis & Rheumatism
  99. Use of a new silica clotting time for diagnosing lupus anticoagulant in patients who meet the clinical criteria for antiphospholipid syndrome
    Panagiotis Grypiotis, Amelia Ruffatti, Vittorio Pengo · 2006 · Journal of Clinical Laboratory Analysis
  100. Syndrome des antiphospholipides avec anticorps antiphosphatidyléthanolamine isolés : à propos de 20 cas
    Christophe Desauw, Eric HACHULLA, Y Boumbar · 2002 · La Revue de Médecine Interne